Cargando…

P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY

Detalles Bibliográficos
Autores principales: Groen, K., Stege, C., Nasserinejad, K., de Heer, K., van Kampen, R., Leys, R., Thielen, N., Westerman, M., Wu, K., Ludwig, I., Issa, D., Velders, G., Vekemans, M., van de Donk, N., Timmers, G., de Boer, F., Tick, L., van der Spek, E., de Waal, E., Sohne, M., Sonneveld, P., Nijhof, I., Klein, S., Levin, M., Ypma, P., Zweegman, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171775/
http://dx.doi.org/10.1097/01.HS9.0000936180.78583.90
_version_ 1785039495273381888
author Groen, K.
Stege, C.
Nasserinejad, K.
de Heer, K.
van Kampen, R.
Leys, R.
Thielen, N.
Westerman, M.
Wu, K.
Ludwig, I.
Issa, D.
Velders, G.
Vekemans, M.
van de Donk, N.
Timmers, G.
de Boer, F.
Tick, L.
van der Spek, E.
de Waal, E.
Sohne, M.
Sonneveld, P.
Nijhof, I.
Klein, S.
Levin, M.
Ypma, P.
Zweegman, S.
author_facet Groen, K.
Stege, C.
Nasserinejad, K.
de Heer, K.
van Kampen, R.
Leys, R.
Thielen, N.
Westerman, M.
Wu, K.
Ludwig, I.
Issa, D.
Velders, G.
Vekemans, M.
van de Donk, N.
Timmers, G.
de Boer, F.
Tick, L.
van der Spek, E.
de Waal, E.
Sohne, M.
Sonneveld, P.
Nijhof, I.
Klein, S.
Levin, M.
Ypma, P.
Zweegman, S.
author_sort Groen, K.
collection PubMed
description
format Online
Article
Text
id pubmed-10171775
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-101717752023-05-11 P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY Groen, K. Stege, C. Nasserinejad, K. de Heer, K. van Kampen, R. Leys, R. Thielen, N. Westerman, M. Wu, K. Ludwig, I. Issa, D. Velders, G. Vekemans, M. van de Donk, N. Timmers, G. de Boer, F. Tick, L. van der Spek, E. de Waal, E. Sohne, M. Sonneveld, P. Nijhof, I. Klein, S. Levin, M. Ypma, P. Zweegman, S. Hemasphere Poster Lippincott Williams & Wilkins 2023-05-09 /pmc/articles/PMC10171775/ http://dx.doi.org/10.1097/01.HS9.0000936180.78583.90 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Poster
Groen, K.
Stege, C.
Nasserinejad, K.
de Heer, K.
van Kampen, R.
Leys, R.
Thielen, N.
Westerman, M.
Wu, K.
Ludwig, I.
Issa, D.
Velders, G.
Vekemans, M.
van de Donk, N.
Timmers, G.
de Boer, F.
Tick, L.
van der Spek, E.
de Waal, E.
Sohne, M.
Sonneveld, P.
Nijhof, I.
Klein, S.
Levin, M.
Ypma, P.
Zweegman, S.
P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY
title P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY
title_full P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY
title_fullStr P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY
title_full_unstemmed P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY
title_short P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY
title_sort p13 ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma; results of the induction and maintenance treatment of the phase ii hovon 143 study
topic Poster
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171775/
http://dx.doi.org/10.1097/01.HS9.0000936180.78583.90
work_keys_str_mv AT groenk p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT stegec p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT nasserinejadk p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT deheerk p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT vankampenr p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT leysr p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT thielenn p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT westermanm p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT wuk p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT ludwigi p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT issad p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT veldersg p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT vekemansm p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT vandedonkn p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT timmersg p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT deboerf p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT tickl p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT vanderspeke p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT dewaale p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT sohnem p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT sonneveldp p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT nijhofi p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT kleins p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT levinm p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT ypmap p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study
AT zweegmans p13ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study